MarketMindsHub

Latin America Bone Graft And Substitutes Market Bone graft substitutes are materials implanted in the human body to replace missing or damaged bones and provide a scaffold or matrix to enable new bone formation. Autologous and allogeneic bone grafts are considered gold standards for bone defect and repair; however, their use is limited due to disadvantages such as donor site morbidity and risk of disease transmission. Bone graft substitutes including bone ceramics, bone morphogenetic proteins (BMP), and synthetic materials offer a suitable alternative for bone repair and regeneration owing to their ability to mimic natural bone and favorable handling properties. Growing geriatric population and increasing cases of bone disorders are major factors driving the demand for effective bone grafting procedures in the region. The Global Latin America Bone Graft And Substitutes Market is estimated to be valued at Us$ 559.36 Mn in 2024 and is expected to exhibit a CAGR Of 5.2% over the forecast...

  Ebola Vaccines Ebola Vaccine: A Major Breakthrough in Containing the Deadly Virus The deadly Ebola virus disease which originated in West Africa in 2014 claimed over 11,000 lives and caused widespread panic globally. After years of intensive research by scientists and medical professionals, there has finally been a major breakthrough - the development of an effective Ebola vaccine. Background of the Ebola Outbreak The Ebola outbreak which started in Guinea quickly spread to neighboring West African countries like Liberia and Sierra Leone. According to the World Health Organization (WHO), it was the largest, most complex and deadliest Ebola outbreak since the virus was first discovered in 1976. The virus spread rapidly in densely populated areas and overwhelmed the poorly equipped local healthcare systems. International aid and medical interventions could not control the virus for several months. The outbreak severely impacted the economies and development of the affected co...

  Ebola Vaccine Market   Ebola vaccines help in preventing Ebola virus disease which is a severe, often fatal illness in humans. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. Ebola vaccines provide protection by training the immune system to recognize and fight the Ebola virus. The need for Ebola vaccines has been increased recently owing to rising cases of Ebola outbreaks across Africa. The global  Ebola Vaccine Market  is estimated to be valued at  Us$ 6.72 Bn  in 2024 and is expected to exhibit a  CAGR Of 9.4%  over the forecast period  2024 To 2030 . Key Takeaways Key players operating in the  Ebola Vaccine Market   are 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode. Key players are focused on developing improved and more effective Ebola vaccines to...

  Swine Fever Vaccine Market Swine fever vaccines are attenuated live vaccines that help prevent the occurrence of Classical Swine Fever (CSF) and African Swine Fever (ASF) in pigs. CSF is highly contagious viral disease of pigs and wild boars that causes severe economic losses to pig farming. Similarly, ASF is a severe hemorrhagic disease of domestic and wild pigs for which till date no vaccine is available. Swine fever vaccines offer natural defense against these diseases and help contain their spread. The global Swine Fever Vaccine Market is estimated to be valued at US$ 3323.81 Billion in 2024 and is expected to exhibit a CAGR Of 11.% over the forecast period 2024-2031 , as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The opportunity for preventing disease occurrence is driving growth of the swine fever vaccine market. Swine fever vaccines can help farms avoid severe outbreaks of CSF and ASF that result in mass culling of infected ...

  Plasmid DNA Manufacturing Market Plasmid DNA is circular DNA molecules occurring in bacteria and other cells. They are used as a tool for cloning genes and in genetic engineering as they are able to self-replicate independently of the chromosomal DNA. Plasmid DNA are considered invaluable to scientific research and have applications in gene therapy, DNA vaccines, genetic engineering, and more. Plasmid DNA is used as a therapeutic agent and as an expression or delivery system for gene therapy. They help deliver therapeutic genes into patients in need of treatment. The global Plasmid DNA Manufacturing Market is estimated to be valued at Us$ 901.2 Bn in 2023 and is expected to exhibit a CAGR Of 4.8% over the forecast period 2023-2030 , as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Gene therapy is a booming biopharmaceutical industry projected to reach over US$ 10 billion by 2030. The opportunity for growth in gene therapy provided by ...

  Humira Biosimilar Market Humira is a biologic treatment for chronic inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis and Crohn's disease. As a biosimilar of Humira, Humira biosimilars hold therapeutic equivalence to the branded reference product Humira with regards to quality, safety and efficacy. The growing prevalence of chronic diseases and increasing healthcare spending on biologics have created significant demand for affordable treatment options like Humira biosimilars. The global Humira Biosimilar Market is estimated to be valued at Us$ 889.46 Bn in 2024 and is expected to exhibit a CAGR Of 10. % over the forecast period 2024 To 2031 , as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends driving the growth of the Humira Biosimilar Market is the patent expiry of Humira and the subsequent launch of its biosimilars. Humira's patents for treating rheumatoid arthritis expired in Europe in...

  Flow Imaging Microscopy   Analysis Market Flow Imaging Microscopy Analysis is an analytical technique used for particle characterization and counting using digital imaging. It provides high resolution digital images of biological and non-biological particles in liquid suspension for analysis. Flow imaging microscopy helps in improving quality control processes in various industries such as pharmaceutical, nutraceutical, and food by analyzing particulate contamination. Increasing R&D expenditure by pharmaceutical companies on drug discovery and quality control processes is driving the demand for flow imaging microscopy globally. The global Flow Imaging Microscopy Analysis Market is estimated to be valued at Us$ 84 Million in 2023 and is expected to exhibit a CAGR Of 8.7% over the forecast period 2023-2031 , as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The increasing adoption of flow imaging microscopy analysis in pharmace...

Tissue And Organ Transplantation Market Tissue and organ transplantation involves replacing damaged or diseased body parts with healthy tissues and organs from donors. Organs like kidney, heart, liver, lungs and pancreas as well as corneas, middle ear, heart valves, skin and bones can be replaced through transplantation. Transplantation enhances the quality of life by restoring impaired organ functions. The global  Tissue And Organ Transplantation Market  is estimated to be valued at  Us$ 20.8 Bn  in 2023 and is expected to exhibit a  CAGR Of 7.9%  over the forecast period  2024 To 2031 , as highlighted in a new report published by Coherent Market Insights. Market key trends The one key trend accelerating growth in the tissue and organ transplantation market is increased organ donation. There is a widening gap between the number of patients requiring organ transplantation and actual organ donations. According to data, over 114,000 patients were on the ...

  Mena   Biologics & Biosimilars Market Biologics & biosimilars are complex biotechnology drugs used to treat various chronic and life-threatening diseases. The major therapeutic areas for biologics include, oncology, autoimmune diseases, hematology, and other clinical indications. The increasing prevalence of chronic diseases and rising healthcare expenditure in MENA countries is expected to drive the growth of the biologics & biosimilars market over the forecast period. The global  Mena   Biologics & Biosimilars Market  is estimated to be valued at  US$ 926 Million  in 2023 and is expected to exhibit a  CAGR Of 1.1%  over the forecast period  2023-2031 , as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Expanding healthcare expenditure in MENA countries presents a lucrative opportunity for players operating in the MENA biologics & biosimilars market. According to data publishe...

  Patient Derived Xenograft Model Market Patient Derived Xenograft (PDX) models involve implantation of intact patient tumors or tumor cells directly into immunodeficient mice. They allow cancer researchers to study cancer biology and test efficacy of new therapeutics in oncology research. PDX models more closely mimic the molecular, cellular, and tumor microenvironment characteristics compared to traditional cell line derived xenograft models. They preserve intratumoral heterogeneity and recapitulate key features of diverse tumor types, their genetic diversity, and therapeutic responses. The global  Patient Derived Xenograft Model Market  is estimated to be valued at  Us$ 30 Million In 2024  and is expected to exhibit a  CAGR Of 4.0%  over the forecast period  2024 To 2031 , as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing adoption of Patient Derived Xenograft Models in oncology research is o...

  Virus Filtration Market The virus filtration market comprises products such as kits, reagents, and systems that are used for removing viruses from biologicalTherapeutics like vaccines and gene therapies require stringent purification processes to remove viruses and ensure patient safety. Virus filtration helps purify biotherapeutic products and remove viral impurities. This purification process is crucial as live viruses could multiply in patients, potentially resulting in new diseases. The global  Virus Filtration Market  is estimated to be valued at  Us$ 5.86 Bn  in 2024 and is expected to exhibit a  CAGR Of 3.1%  over the forecast period  2024 To 2031 , as highlighted in a new report published by Coherent Market Insights. Market key trends: Rapid adoption of virus filtration in the biopharmaceutical industry has been a key trend fueling the market growth. Virus filtration is increasingly being used downstream and upstream in bioproduction pro...